Navigation Links
Coffee in capsules contains more furan than the rest
Date:4/13/2011

values of 0.03‐0.38 micrograms/kilogram of body weight, which is less than the maximum acceptable level (2 μg/Kg of body weight).

In order for furan ingestion to exceed the maximum acceptable values, a person would have to drink at least 20 cups of capsule coffee or 30 espressos per day (for the brands with the highest furan content), or 200 instant coffees. These estimates were made on the basis of 40 ml cups and an average body weight for coffee drinkers of around 70 Kg.

The study also shows that furan concentrations are lower if coffee is roasted at low temperatures over a longer time (140C for 20 minutes) than in coffee roasted under usual conditions (200‐220C for 10-15 mins).

Furan, like acrylamide, is one of a group of carcinogenic substances that can form when foods and drinks are subject to heat treatment. They are the result of a reaction, known as the Maillard reaction, between carbohydrates, unsaturated fatty acids and ascorbic acids or its derivatives.


'/>"/>

Contact: SINC
info@plataformasinc.es
34-914-251-820
FECYT - Spanish Foundation for Science and Technology
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Coffee Addiction May Be Grounded in Genes
2. Can Coffee Cut a Womans Stroke Risk?
3. Coffee, Sex, Smog Can All Trigger Heart Attack, Study Finds
4. Can Coffee, Tea Lower Brain Cancer Risk?
5. MimicCreme Announces the Release of its Dairy-Free Whipping Cream - HealthyTop and Two New Flavored Coffee Creamers.
6. Coffee may protect against head and neck cancers
7. Coffee Might Guard Against Head, Neck Cancers
8. Moderate Coffee, Tea Drinking Lowers Heart Disease Risk
9. New evidence that drinking coffee may reduce the risk of diabetes
10. Coffees Jolt Just an Illusion?
11. Coffee and soft drinks have little or no association with colon cancer risk
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Coffee in capsules contains more furan than the rest
(Date:8/5/2015)... , ... August 05, 2015 , ... Available in select ... serum formulated with a quartet of beauty-enhancing marine and plant oils. A perfect complement ... rose oil which stands out for its lovely scent and soothing properties. Formulated as ...
(Date:8/5/2015)... ... , ... Over 6,500 athletes from 177 nations recently descended upon the Los ... World Games 2015 (July 25 to August 2). , Officially opened by First Lady ... since the 1984 Olympics, and the Los Angeles Coliseum was once again filled up ...
(Date:8/4/2015)... ... 05, 2015 , ... In reaction to a pending NYS ... gas (LPG) next to Seneca Lake*, the full Executive Committee of 1199SEIU United ... strongly opposes that permit. *, ** , “1199SEIU healthcare workers have always been ...
(Date:8/4/2015)... City, NY (PRWEB) , ... August 05, 2015 ... ... honors Deborah Stevens as a 2015-2016 inductee into its VIP ... leadership in business. NAPW is the nation’s leading networking organization exclusively for professional ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... Statement by ... applauds the introduction of the Mental Health Reform Act of 2015 by ... comprehensive mental health reform a reality in America. , “This legislation and ...
Breaking Medicine News(10 mins):Health News:Phytomer launches ROSÉE SOIN Radiance Replenishing Oil 2Health News:Phytomer launches ROSÉE SOIN Radiance Replenishing Oil 3Health News:Phytomer launches ROSÉE SOIN Radiance Replenishing Oil 4Health News:CPMA Member Podiatrists Ensure Fit Feet at the Special Olympics World Games in Los Angeles 2Health News:CPMA Member Podiatrists Ensure Fit Feet at the Special Olympics World Games in Los Angeles 3Health News:Opposition Mounting to Permit Liquid Propane Gas Storage Next to New York’s Seneca Lake 2Health News:Opposition Mounting to Permit Liquid Propane Gas Storage Next to New York’s Seneca Lake 3Health News:NAPW Inducts Deborah Stevens, Executive Assistant to Chairman and CEO at Mirion Technologies, Inc., Into its VIP Woman of the Year Circle 2Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 2Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 3
... Company,(Nasdaq: PRGO ; TASE) today announced that it ... Cream 0.1%, a generic version of,VANOS(R) Cream 0.1%. The ... an,ANDA with a Paragraph IV certification against VANOS(R)., ... to relieve the inflammation and itching caused by certain,skin ...
... suggest current dietary requirements need to be increased , , MONDAY, ... the risk of heart attack in men, says a U.S. ... and Brigham and Women,s Hospital, Boston, analyzed medical records and ... had a nonfatal heart attack or fatal heart disease, and ...
... Francisco, Calif., June 07, 2008 Results from ... announced today at the American Diabetes Association (ADA) ... Development Center, Inc. Alogliptin, which has been ... dipeptidyl peptidase-4 (DPP-4), is currently under investigation as ...
... June 9 The Department of,Labor & Industry invites the ... the 10th annual Health & Safety Day from 10 a.m. ... Wing Rotunda in,Harrisburg., The event will feature an array ... home. Visitors to the event can,receive - free of charge ...
... wheel, with 2.2% reporting accidents as result , , MONDAY, June ... of sleep may be a real problem for American college ... at the University of North Texas found that 17 percent ... that group reported having accidents because of this drowsiness. A ...
... College of Physicians (ACP) today pledged its support for ... Patients and Providers Act of 2008. , "The College ... addresses and incorporates three of our top legislative priorities," ... Max Baucus (D-MT), chairman of the Senate Finance Committee. ...
Cached Medicine News:Health News:Perrigo Confirms Filing for Generic Version of VANOS(R) 2Health News:Phase 3 results for alogliptin 2Health News:Phase 3 results for alogliptin 3Health News:Sleepy Driving Prevalent Among Collegians 2Health News:ACP pledges support for Medicare improvements for Patients and Providers Act of 2008 2
(Date:8/4/2015)... 4, 2015 BioElectronics Corporation (OTC Pink: ... Pain Therapy medical devices, announced today that its ... 7-day trial device has been published in the ... http://www.futuremedicine.com/doi/full/10.2217/PMT.15.35 .  More than 5,000 chronic ... an assessment.  Chronic pain is ...
(Date:8/4/2015)... 2015 Second Quarter 2015 Highlights: ... second quarter of 2014 , Net earnings attributable to ... million after adjustments , Diluted net earnings per share ... increased 15.2% to $99.4 million 2015 Outlook: ... range of 24.0% to 26.0%; Adjusted EBITDA margin remains between ...
(Date:8/4/2015)... Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP ) today reported ... June 30, 2015 and updated its financial guidance for ... this morning, August 4, 2015, at 10:30 AM ET. ... by dialing (855) 582-8078. The conference ID is 90889796. ... revenues of $38.3 million, an increase of 118% as compared ...
Breaking Medicine Technology:BioElectronics' Landmark 5,000+ Chronic Pain Patient Study Published in Pain Management Medical Journal 2Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 2Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 3Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 4Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 5Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 6Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 7Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 8Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 9Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 10Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 11Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 12Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 13Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 14Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 15Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 16Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 17Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 18Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 19Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 20Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 21Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 22Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 23Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 24Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 25Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 26Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 27Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 28Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 29Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 30Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 31Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 32Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 33ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 2ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 3
... First Presentation of Full Data Set from the TRIUMPH-1 Trial of ... ... SPRING, Md., May 21 United,Therapeutics Corporation (Nasdaq: UTHR ) ... seven presentations concerning,the treatment of pulmonary arterial hypertension (PAH) with treprostinil,were ...
... of Four HUMIRA Patients from CHARM Study in Remission at ... ... 21 Results from an,open-label extension study of two Abbott ... treated with,HUMIRA(R) (adalimumab) achieved long-term clinical remission and clinical,response, respectively, ...
Cached Medicine Technology:Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 2Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 3Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 4Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 5Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 6Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 2Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 3Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 4Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 5Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 6Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 7
The Vitatron Slimtine S lead series are endocardial leads with an excellent history of reliability and optimal handling en pacing performance....
Bipolar Atrial "J" Lead...
Unipolar temporary atrial pacing lead is smaller and thinner than Medtronics standard temporary pacing leads. It is well suited for thin, delicate, atrial tissue....
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
Medicine Products: